In this article, we discuss in detail the current literature that describes the biology of LAG-3, the relevance of this inhibitory receptor in T cell immunomodulation during ALRTIs caused by the most prevalent respiratory viruses, and the therapeutic potential of this molecule during viral infections. Here, LAG3 is linked to viral infectious disease.